awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36361289-0AE023CE-81E6-43A1-B345-D876EB3D4911
Q36361289-0AE023CE-81E6-43A1-B345-D876EB3D4911
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36361289-0AE023CE-81E6-43A1-B345-D876EB3D4911
Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study.
P2860
Q36361289-0AE023CE-81E6-43A1-B345-D876EB3D4911
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36361289-0AE023CE-81E6-43A1-B345-D876EB3D4911
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f95a8c2e26c11035023b2945498962d722dd75c0
P2860
Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial.